Replicel Life Sciences Stock Analysis
| RP Stock | CAD 0.01 0.00 0.00% |
RepliCel Life Sciences is overvalued with Real Value of 0.0096 and Hype Value of 0.01. The main objective of RepliCel Life stock analysis is to determine its intrinsic value, which is an estimate of what RepliCel Life Sciences is worth, separate from its market price. There are two main types of RepliCel Life's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect RepliCel Life's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of RepliCel Life's stock to identify patterns and trends that may indicate its future price movements.
The RepliCel Life stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. RepliCel Life is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. RepliCel Stock trading window is adjusted to America/Toronto timezone.
RepliCel |
RepliCel Stock Analysis Notes
About 59.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. RepliCel Life Sciences last dividend was issued on the 10th of August 2016. The entity had 1:10 split on the 10th of August 2016. RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada. REPLICEL LIFE operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To find out more about RepliCel Life Sciences contact Andrew Schutte at 604 248 8730 or learn more at https://www.replicel.com.RepliCel Life Sciences Investment Alerts
| RepliCel Life generated a negative expected return over the last 90 days | |
| RepliCel Life has high historical volatility and very poor performance | |
| RepliCel Life has some characteristics of a very speculative penny stock | |
| RepliCel Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 353.74 K. Net Loss for the year was (311.73 K) with profit before overhead, payroll, taxes, and interest of 353.74 K. | |
| RepliCel Life Sciences currently holds about 1.16 M in cash with (1.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: RepliCel Life Sciences Urges Online Access for Shareholders - TipRanks |
RepliCel Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 735.78 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RepliCel Life's market, we take the total number of its shares issued and multiply it by RepliCel Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.RepliCel Profitablity
RepliCel Life's profitability indicators refer to fundamental financial ratios that showcase RepliCel Life's ability to generate income relative to its revenue or operating costs. If, let's say, RepliCel Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, RepliCel Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of RepliCel Life's profitability requires more research than a typical breakdown of RepliCel Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 2.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of (0.74) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.74. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.08) | (1.14) | |
| Return On Capital Employed | 0.90 | 0.95 | |
| Return On Assets | (1.08) | (1.14) | |
| Return On Equity | 0.07 | 0.07 |
Management Efficiency
RepliCel Life Sciences has return on total asset (ROA) of (1.5334) % which means that it has lost $1.5334 on every $100 spent on assets. This is way below average. RepliCel Life's management efficiency ratios could be used to measure how well RepliCel Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, RepliCel Life's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (1.14) in 2024. At this time, RepliCel Life's Other Current Assets are fairly stable compared to the past year. Debt To Assets is likely to climb to 3.19 in 2024, whereas Non Current Assets Total are likely to drop slightly above 119.4 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.08) | (0.08) | |
| Net Current Asset Value | -3.7 M | -3.5 M | |
| Tangible Book Value Per Share | (0.08) | (0.08) | |
| Enterprise Value Over EBITDA | (3.37) | (3.54) | |
| Price Book Value Ratio | (0.85) | (0.81) | |
| Enterprise Value Multiple | (3.37) | (3.54) | |
| Price Fair Value | (0.85) | (0.81) | |
| Enterprise Value | 4.7 M | 8.4 M |
Leadership effectiveness at RepliCel Life Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (0.74) | Profit Margin 2.1572 | Beta 0.949 | Return On Assets (1.53) |
Technical Drivers
As of the 18th of December 2024, RepliCel Life holds the Risk Adjusted Performance of (0.02), coefficient of variation of (2,827), and Variance of 441.99. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of RepliCel Life, as well as the relationship between them. Please check RepliCel Life Sciences market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if RepliCel Life Sciences is priced some-what accurately, providing market reflects its current price of 0.01 per share.RepliCel Life Sciences Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. RepliCel Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for RepliCel Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
RepliCel Life Outstanding Bonds
RepliCel Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. RepliCel Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most RepliCel bonds can be classified according to their maturity, which is the date when RepliCel Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
RepliCel Life Predictive Daily Indicators
RepliCel Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of RepliCel Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
RepliCel Life Forecast Models
RepliCel Life's time-series forecasting models are one of many RepliCel Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary RepliCel Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About RepliCel Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how RepliCel Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling RepliCel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as RepliCel Life. By using and applying RepliCel Stock analysis, traders can create a robust methodology for identifying RepliCel entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.88) | (0.93) | |
| Operating Profit Margin | (3.92) | (4.11) | |
| Net Loss | (0.88) | (0.93) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding RepliCel Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.